Company profile

Founded in 1996 by Dr. FX. Bernard & Dr. A. Deguercy, BIOalternatives is a private company (Contract Research Organization) specialized in Cellular and Molecular Pharmacology. BIOalternatives provides services to support the early stages of drug discovery and the claim substantiation of healthcare compounds using up-to-date in vitro solutions.

BIOalternatives develops and manages informative cell-based assays allowing faster and cost-effective selection of your compounds, our capabilities include:

• in vitro model & development,
• Development & management of cell-based assays,
• Biological target identification,

• Primary and secondary screening (including High Content Screening) for hit to lead identification,
• Profiling, mechanism of action studies; proof-of-concept evidencing,
• Running of in vitro safety and toxicity assays,


• Analysis of preclinical/ clinical samples
  

BIOalternatives has a special expertise in:

• Epithelial cell and tissue models,
• Neural cell and tissue models,
• Mesenchymal cell and tissue models,
• Blood-derived immuno-inflammatory cells.
  

With 15 years of experience and more than 600 in vitro assays already developed, BIOalternatives provides services and customized solutions to more than 200 companies including the world's top pharmaceutical, nutraceutical and dermo-cosmetic industries.